1997
DOI: 10.1007/s002620050384
|View full text |Cite
|
Sign up to set email alerts
|

The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent

Abstract: Cytotoxic T lymphocytes and natural killer (NK) cells kill target cells by two main mechanisms, namely, the perforin/granzymes and the Fas ligand (Fas-L) pathways. The preferential activation of either of these two mechanisms by target cells is not known. This study examined whether various NK stimuli regulate preferentially the perforin/granzyme or the Fas pathways during the NK-cell-mediated cytotoxic reaction (NK-CMC). Purified peripheral-blood-derived NK cells were stimulated with interleukin-2 (IL-2), IL-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
44
1
1

Year Published

1997
1997
2004
2004

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 60 publications
(49 citation statements)
references
References 0 publications
3
44
1
1
Order By: Relevance
“…In this study, we observed that treatment of DLD-1 cells with actinomycin D reduced the expression level of FAP-1 mRNA and enhanced Fas-induced apoptosis dramatically. These results are consistent with the recent report that actinomycin D-treatment of AIDS-associated Kaposi's sarcoma cells down-regulates FAP-1 mRNA and also sensitized these cells to Fasinduced apoptosis (44).…”
Section: T(s/t)-x-(v/l/i)supporting
confidence: 83%
“…In this study, we observed that treatment of DLD-1 cells with actinomycin D reduced the expression level of FAP-1 mRNA and enhanced Fas-induced apoptosis dramatically. These results are consistent with the recent report that actinomycin D-treatment of AIDS-associated Kaposi's sarcoma cells down-regulates FAP-1 mRNA and also sensitized these cells to Fasinduced apoptosis (44).…”
Section: T(s/t)-x-(v/l/i)supporting
confidence: 83%
“…Altogether our data on apoptosis in wildtype and PTPL1 antisense transfectants are therefore concordant with the concept that PTPL1 is a pro-apoptotic enzyme in estrogen receptor-positive breast cancer cells by early inhibition of the PI3-K/Akt pathway. (31)(32)(33), whereas other groups failed to find such a correlation (34 -36), which altogether seemed to highly depend on the cell line examined and therefore strongly suggested that it was a tissueor a cell-specific event. We have evaluated the ability of an anti-Fas antibody to induce apoptosis in three estrogen-sensitive breast cancer cell lines, which expressed varying levels of PTPL1/FAP-1, wild-type MCF7 cells (low expression), T47D cells (3.5-fold more expression than in MCF7 cells) (Fig.…”
Section: Ptpl1-induced Apoptosis Is Mediated By Inhibition Of the Pi3mentioning
confidence: 81%
“…Some studies have provided evidence for a high level of FAP-1 mRNA expression in Kaposi's sarcoma (31) and, in pancreatic adenocarcinomas (33), a higher expression in T helper cells type 1 (which are resistant to apoptosis) than in T helper cells type 2 (which are sensitive to Fas ligand) (32). Other groups failed to show any correlation between Fas resistance and FAP-1 expression in colon cancer (34), in subclones of S49.1 murine T lymphocytes (35), in adult T cell leukemia cell lines (36), and in testicular germ cells where exposure to mono-(2-ethylhexyl) phthalate induces massive cell death and increases FAP-1 expression (47).…”
Section: Ptpl1/fap-1 Apoptotic Effect Is Independent Of the Fasmentioning
confidence: 99%
“…Recent studies have also demonstrated that T cells specific for tumour antigens can become actively tolerated during progression of tumours (Mackensen et al, 1993;Adler et al, 1998). It is possible that altered T cells may produce a distinct profile of cytokine productions, which in turn stimulate tumour formation (Medvedev et al, 1997;Mori et al, 1997). …”
Section: Discussionmentioning
confidence: 99%